KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Ingredients (ALTO) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Alto Ingredients (ALTO) over the last 15 years, with Q3 2025 value amounting to -$2.7 million.

  • Alto Ingredients' Change in Receivables rose 7753.56% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 12190.29%. This contributed to the annual value of -$562000.0 for FY2024, which is 9408.36% up from last year.
  • Per Alto Ingredients' latest filing, its Change in Receivables stood at -$2.7 million for Q3 2025, which was up 7753.56% from -$7.5 million recorded in Q2 2025.
  • In the past 5 years, Alto Ingredients' Change in Receivables registered a high of $13.1 million during Q1 2021, and its lowest value of -$16.5 million during Q3 2022.
  • Over the past 5 years, Alto Ingredients' median Change in Receivables value was -$675000.0 (recorded in 2024), while the average stood at $334000.0.
  • Per our database at Business Quant, Alto Ingredients' Change in Receivables surged by 126191.78% in 2021 and then crashed by 54680.3% in 2024.
  • Over the past 5 years, Alto Ingredients' Change in Receivables (Quarter) stood at $8.5 million in 2021, then plummeted by 192.31% to -$7.8 million in 2022, then increased by 12.45% to -$6.9 million in 2023, then soared by 189.74% to $6.2 million in 2024, then crashed by 143.89% to -$2.7 million in 2025.
  • Its Change in Receivables was -$2.7 million in Q3 2025, compared to -$7.5 million in Q2 2025 and $7.0 million in Q1 2025.